The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature Review.

Published in: Cancer control : journal of the Moffitt Cancer Center (2021)

For the treatment of advanced gastric esophageal cancer, the therapeutic efficacy of anti-PD-1/PD-L1 immunotherapy was superior to that of chemotherapy or palliative care.

Keyphrases

palliative care
case report
advanced cancer
locally advanced
squamous cell carcinoma
chemotherapy induced